Antibodies

12 Jun 2008 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
12 Jun 2008 ORENCIA(R) (abatacept) Provided an Increasing Degree of Inhibition of Structural Damage Through Three Years in Adults with Moderate to Severe Rheumatoid Arthritis
11 Jun 2008 Ofatumumab in subcutaneous study in rheumatoid arthritis
11 Jun 2008 Phase 3 Data Show Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-TNF Agents
10 Jun 2008 Symphogen Enters into strategic collaboration with Genentech for antibody thera-peutics
09 Jun 2008 Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma
09 Jun 2008 XOMA 052 Demonstrates Anti-Inflammatory Effect in Arthritis Animal Studies; Data Presented At FOCIS
08 Jun 2008 WILEX and IBA enter into worldwide marketing, distribution and sales agreement on REDECTANE(R) (CA9-SCAN)
05 Jun 2008 Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma
05 Jun 2008 Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
05 Jun 2008 Merck Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
05 Jun 2008 Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin Lymphoma Data at International Conference on Malignant Lymphoma
04 Jun 2008 ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Findings with Trastuzumab-DM1 at ASCO
04 Jun 2008 Seattle Genetics Reports Multiple Complete and Partial Responses with SGN-35 in Patients with Lymphoma
04 Jun 2008 BioInvent and ThromboGenics report positive Phase I results for anti-PlGF cancer therapeutic TB-403
04 Jun 2008 Bradmer Receives FDA Approval to Proceed with Phase III Clinical Trial
03 Jun 2008 Seattle Genetics Announces Initiation of SGN-40 Phase Ib Clinical Trial in Combination With Velcade for Multiple Myeloma
03 Jun 2008 Trubion Announces Presentation of Positive TRU-016 Data at ASCO
03 Jun 2008 New Pfizer Data Presented on CP-751,871 across Non-Small Cell Lung Cancer and Ewing’s Sarcoma
03 Jun 2008 Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
03 Jun 2008 Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting
02 Jun 2008 Study confirms that Avastin significantly increases chance of living without disease progression in metastatic breast cancer
02 Jun 2008 ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
02 Jun 2008 New Ipilimumab Survival Data in Patients with Metastatic Melanoma Presented at American Society of Clinical Oncology Annual Meeting
02 Jun 2008 Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top